Jeffrey D. Alter's most recent trade in Biora Therapeutics Inc was a trade of 12,500 Common Stock done . Disclosure was reported to the exchange on June 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 31,546 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 19,046 | - | 0 | Common Stock | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jan 2023 | 65 | 0 | - | - | Series X Preferred Stock | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 148,810 | 148,810 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 96,154 | 163,672 | - | 0 | Common Stock | |
| Elevance Health | Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Payment of exercise price or tax liability using portion of securities received from the company at price $ 375.93 per share. | 01 Oct 2021 | 311 | 5,107 (0%) | 0% | 375.9 | 116,914 | Common Stock |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 51,724 | 51,724 | - | - | Stock Option (Right to Buy) | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 29,183 | 67,518 | - | 0 | Common Stock | |
| Elevance Health | Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 10,876 | 10,876 | - | - | Employee Stock Option (Right to Buy) | |
| Elevance Health | Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 2,649 | 5,395 (0%) | 0% | 0 | Common Stock | |
| Biora Therapeutics Inc | Jeffrey D. Alter | Director | Purchase of securities on an exchange or from another person at price $ 4.85 per share. | 14 Dec 2020 | 20,000 | 38,335 | - | 4.9 | 97,000 | Common Stock |